Abstract:BackgroundPlacenta previa is major obstetric surgical risk as it is associated with higher percentage of intraoperative and postpartum hemorrhage (PPH), increased requirement of blood transfusion and further surgical procedures. The current study aimed to evaluate uterine artery ligation prior to uterine incision as a procedure to minimize blood loss during cesarean section in patients with central placenta previa.MethodsOne hundred and four patients diagnosed with central placenta previa antenatally and plann… Show more
“…The combination of more than hemostatic measure before removal of placenta could explain the excellent outcome in the current study. These results agree with Zhao et al [8] , Tskhay et al [9] and Sanad et al [10] regarding patient age, gravidity, parity and residence.…”
Background: Morbidity attached placenta [MAP] remain a major surgical problem for obstetricians due to severe hemorrhage and its incidence had been continually increased due to increased rate of cesarean deliveries. Aim of the work: To evaluate the safety and efficacy of a conservative intervention for management of placenta accreta. Patients and Methods: Forty-eight, pregnant females with a confirmed diagnosis of placenta previa accreta had been scheduled for elective cesarean delivery had been included. All females had been screened by full history taking, clinical examination, ultrasound and laboratory investigations. Blood loss, operative time, need for transfusion and need for other surgical interventions represented the main outcome and other complications were documented. Results: The blood loss [ml] ranged between 850 to 1300 ml; the mean values were 1082.29±105.89 ml. The operative time ranged between 60 to 130 minutes; the mean values were 87.92±19.35 minutes. There was significant decrease of post-partum hemoglobin when compared to corresponding pre-partum values [9.29±0.76 vs 10.71±0.54 mg/dl respectively]. Four patients [8.3%] need ICU admission, and nine patients [18.75%] need blood transfusion. However, no patients need further surgical intervention or developed DIC. In addition, no mortality had been reported in the current work. Conclusion: Combined uterine artery ligation, partial segmental myometrial resection and intrauterine balloon as a conservative treatment modality or placenta previa accreta is safe and effective.
“…The combination of more than hemostatic measure before removal of placenta could explain the excellent outcome in the current study. These results agree with Zhao et al [8] , Tskhay et al [9] and Sanad et al [10] regarding patient age, gravidity, parity and residence.…”
Background: Morbidity attached placenta [MAP] remain a major surgical problem for obstetricians due to severe hemorrhage and its incidence had been continually increased due to increased rate of cesarean deliveries. Aim of the work: To evaluate the safety and efficacy of a conservative intervention for management of placenta accreta. Patients and Methods: Forty-eight, pregnant females with a confirmed diagnosis of placenta previa accreta had been scheduled for elective cesarean delivery had been included. All females had been screened by full history taking, clinical examination, ultrasound and laboratory investigations. Blood loss, operative time, need for transfusion and need for other surgical interventions represented the main outcome and other complications were documented. Results: The blood loss [ml] ranged between 850 to 1300 ml; the mean values were 1082.29±105.89 ml. The operative time ranged between 60 to 130 minutes; the mean values were 87.92±19.35 minutes. There was significant decrease of post-partum hemoglobin when compared to corresponding pre-partum values [9.29±0.76 vs 10.71±0.54 mg/dl respectively]. Four patients [8.3%] need ICU admission, and nine patients [18.75%] need blood transfusion. However, no patients need further surgical intervention or developed DIC. In addition, no mortality had been reported in the current work. Conclusion: Combined uterine artery ligation, partial segmental myometrial resection and intrauterine balloon as a conservative treatment modality or placenta previa accreta is safe and effective.
“…Os quatorze estudos fizeram caracterização clínica das intervenções, conforme mostra o quadro 4. Todos os estudos descreveram o tipo de parto onde ocorreu a intervenção no manejo da hemorragia pós-parto, sendo prevalente o parto vaginal (Rangel et al, 2019;Begley et al, 2019;Salati et al, 2019;Asmat et al, 2017;Quibel et al, 2016;Suarez et al, 2020;Escobar et al, 2020;Şentürk et al, 2016;Sanad et al, 2018;Gallos et al, 2018;Woman et al, 2017;Anger et al, 2019;Maged et al, 2019;Amornpetchakul et al, 2018).…”
Section: Caracterização Dos Estudos Analisadosunclassified
“…Quanto a perda sanguínea das puérperas na hemorragia pós-parto, os seguintes estudos mostraram que o volume variou de ≥500 a ≥2000mL (Begley et al, 2019;Salati et al, 2019;Asmat et al, 2017;Quibel et al, 2016;Suarez et al, 2020;Escobar et al, 2020;Şentürk et al, 2016;Sanad et al, 2018;Gallos et al, 2018;Woman et al, 2017;Maged et al, 2019;Amornpetchakul et al, 2018).…”
Section: Caracterização Dos Estudos Analisadosunclassified
“…gestantes multíparas, grandes multíparas, placenta prévia, placenta acreta, placenta retida, descolamento prematuro de placenta, atonia uterina, coagulopatia, produtos retidos da concepção, distúrbios hipertensivos e nuliparidade (Asmat et al, 2017;Suarez et al, 2020;Escobar et al, 2020;Sanad et al, 2018;Amornpetchakul et al, 2018).…”
Section: Caracterização Dos Estudos Analisadosunclassified
“…Um número relativamente pequeno de estudos realizou caracterização sociodemográfica, nos estudos que avaliaram, a faixa etária variou de 18 a 44 anos (Asmat et al, 2017;Şentürk et al, 2016;Sanad et al, 2018;Woman et al, 2017;Anger et al, 2019;Maged et al, 2019;Amornpetchakul et al, 2018).…”
Section: Caracterização Dos Estudos Analisadosunclassified
A hemorragia pós-parto (HPP) é definida como uma perda de sangue ≥ 500 mL que acontece nas 24 horas após o parto, quando essa perda é maior que 1.000 mL é considerada grave. A HPP está entre as principais causas de morbidades maternas graves, responsável por cerca de 25% de todas as mortes de gestantes no mundo, sobretudo em países de baixa renda. No Brasil ocupa a segunda maior causa de morte materna. Este estudo teve como objetivo analisar a produção científica acerca das intervenções utilizadas na prevenção e controle da hemorragia pós-parto. Tratou-se de uma pesquisa bibliográfica do tipo revisão integrativa da literatura, os estudos foram extraídos das bases de dados PubMed (National Library of Medicine); BVS (Biblioteca Virtual da Saúde) e CINAHL (Cumulative Index to Nursing and Allied Health Literature). Utilizou-se 14 estudos publicados nos anos de 2016 à 2021. O nível de evidencia predominante foi II - ensaio clínico randomizado, 11 estudos obtiveram grau de recomendação A. Os resultados concluem que, as intervenções analisadas como efetivas para a prevenção da hemorragia pós-parto foram: ocitocina, misoprostol, carbetocina, ergometrina ou metilergometrina, o manejo ativo no terceiro período do trabalho de parto e a ligadura da artéria uterina. No controle da HPP foram: o ácido tranexâmico, tamponamento com balão uterino (BTU) e o traje anti-choque não pneumático (NASG).
ObjectiveTo assess the effectiveness of prophylactic bilateral uterine artery ligation (BUAL) in reducing the incidence of postpartum hemorrhage (PPH) during cesarean delivery among women at risk of uterine atony.MethodsA randomized clinical trial at Cairo University Maternity Hospital, Egypt, from December 2017 to December 2018. Women at risk of uterine atony undergoing scheduled or emergency cesarean were randomized to two groups. In the BUAL group, women underwent BUAL before placental delivery; in the control group, women had cesarean delivery without BUAL. The primary outcome was the estimated blood loss during cesarean.ResultsIntraoperative blood loss during cesarean was significantly lower in the BUAL group than in the control group (523.4 ± 41.0 vs 619.6 ± 36.1 mL; P=0.003). Blood loss in the first 6 hours after cesarean was also significantly lower in the BUAL group than in the control group (246.1 ± 21.4 vs 326.1 ± 18.5 mL; P=0.006). There was no difference in operative time between the two groups (52.1 ± 6.1 vs 52.2 ± 6.8, P=0.880).ConclusionBUAL during cesarean was found to be an effective method for decreasing blood loss during and after cesarean delivery among women at risk of uterine atony and subsequent PPH.ClinicalTrials.gov: NCT03591679
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.